Brief: Astrazeneca Pharma India Gets Permission To Import For Sale And Distribution Of Trastuzumab Deruxtecan Lyophilized Powder
26/03/2024 13:29
March 26 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* ASTRAZENECA PHARMA INDIA LTD - RECEIVED PERMISSION TO
IMPORT FOR
SALE AND DISTRIBUTION OF TRASTUZUMAB DERUXTECAN LYOPHILIZED
POWDER
* ASTRAZENECA PHARMA INDIA LTD - RECEIVED PERMISSION FROM
CENTRAL
DRUGS STANDARD CONTROL ORGANISATION, INDIA
Source text for Eikon: ID:nBSE1W8hCD
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication